4//SEC Filing
Topper David Joseph 4
Accession 0001787306-24-000050
CIK 0001787306other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 8:32 PM ET
Size
7.4 KB
Accession
0001787306-24-000050
Insider Transaction Report
Form 4
Topper David Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2024-04-10+110,000→ 110,000 total - Award
Stock Option (right to buy)
2024-04-10+310,000→ 310,000 totalExercise: $12.34Exp: 2034-04-10→ Common Stock (310,000 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest as to 25% of the RSUs on each annual anniversary of April 10, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]The option will vest and become exercisable as to 25% of the shares on the first annual anniversary of the grant date of April 10, 2024, and the remaining options will vest at 2.0833%, on each monthly anniversary thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001740378
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 8:32 PM ET
- Size
- 7.4 KB